Cargando…

Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer

BACKGROUND: This study sought to perform a survival analysis and construct a prognostic nomogram model based on the Gleason grade, total prostate-specific antigen (tPSA), alkaline phosphate (ALP), and TNM stage in patients with prostate cancer (PCa). METHODS: The progression-free survival (PFS) of 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yuefu, Wen, Xingqiao, Chen, Dong, Li, Xiaojuan, Leng, Qu, Wen, Yuehui, Li, Jun, Zhu, Weian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964199/ https://www.ncbi.nlm.nih.gov/pubmed/35359343 http://dx.doi.org/10.1155/2022/6358707

Ejemplares similares

MicroRNA‐488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3
por: Wang, Jun, et al.
Publicado: (2019)

HJURP promotes proliferation in prostate cancer cells through increasing CDKN1A degradation via the GSK3β/JNK signaling pathway
por: Lai, Wenjie, et al.
Publicado: (2021)

Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress malignant characteristics and promote apoptosis in prostate cancer cells
por: Han, Yuefu, et al.
Publicado: (2021)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Novel Prognostic Nomogram to Predict Progression-Free Survival of Patients with Hepatocellular Carcinoma After Transarterial Chemoembolization
por: Xi, Dong, et al.
Publicado: (2023)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

CT-Based Radiomics Nomogram for Prediction of Progression-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Yan, Chang, et al.
Publicado: (2021)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer
por: Zhu, Weian, et al.
Publicado: (2023)

Development of A Nomogram for Progression-free Survival in Patients with Stage II/T3N0 Nasopharyngeal Carcinoma to Explore Different Treatment Modalities
por: Yan, Chang, et al.
Publicado: (2023)

Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor
por: Ran, Pan, et al.
Publicado: (2023)

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
por: Lee, C K, et al.
Publicado: (2011)

A Nomogram Predicting the Progression-Free Survival of Nonmetastatic Renal Cell Carcinoma Patients With Venous Thrombus After Surgery
por: Zhang, Yu, et al.
Publicado: (2022)

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
por: Liu, Yi, et al.
Publicado: (2022)

Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)

Prognostic Nomograms for Hospital Survival and Transplant-Free Survival of Patients with Hepatorenal Syndrome: A Retrospective Cohort Study
por: Song, Yi, et al.
Publicado: (2022)

A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection
por: Leng, Changsen, et al.
Publicado: (2022)

Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
por: Chang, Runsheng, et al.
Publicado: (2023)

Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Takuma, Yoshitaka, et al.
Publicado: (2017)

Development and validation of a novel nomogram for predicting overall survival in gastric cancer based on inflammatory markers
por: Luo, Pan-Quan, et al.
Publicado: (2023)

A nomogram to predict stricture-free survival in patients with ureteral stricture after balloon dilation
por: Hu, Jintao, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Survival in Patients with Thyroid Cancer
por: Wen, Qian, et al.
Publicado: (2019)

Development of a nomogram to predict progression-free survival in patients with locally advanced renal cell carcinoma
por: Xiao, Ruo-Tao, et al.
Publicado: (2021)

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma
por: Yan, Ting, et al.
Publicado: (2022)

A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
por: Zhang, Zehan, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma
por: Yang, Yao-Cheng, et al.
Publicado: (2021)

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2023)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

Development and validation of a preoperative MRI-based radiomics nomogram to predict progression-free survival in patients with clival chordomas
por: Zhai, Yixuan, et al.
Publicado: (2022)

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2015)

Bias in progression‐free survival analysis due to intermittent assessment of progression
por: Zeng, Leilei, et al.
Publicado: (2015)

External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
por: Yang, Yun-Jie, et al.
Publicado: (2018)

A novel nomogram to predict the overall survival in esthesinoeroblastoma
por: Jiang, Lijie, et al.
Publicado: (2020)

Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients with Major Salivary Gland Mucoepidermoid Carcinoma
por: Hu, Jia-Qian, et al.
Publicado: (2019)

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I–III Renal Cell Carcinoma
por: Zhang, Haijie, et al.
Publicado: (2022)

Nomograms and scoring system for forecasting overall and cancer‐specific survival of patients with prostate cancer
por: Zhou, Yuan, et al.
Publicado: (2022)

A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters
por: Chang, Yau-Ren, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dgco2s7jn3h179j6ek0cdeoqb